Pharma Industry
Industry: Email Alert RSS FeedApplied Genetics News
View more issues: June 1, 1998, July 1, 1998, Sept 1, 1998
Articles in August 1, 1998, issue of Applied Genetics News
- Procedure Repairs Damaged Brains
- Brewery Gets into Bioengineering
- Drug Expands Bone Marrow Population
- Combining Resources Advances Plant Biotech
- BIOPROCESSING: To Find Proteins, Try "Flash"
- ANTI-INFECTIVES: Killer T's Activated in Late-Stage AIDS
- Alfalfa Crop Gets Boost from Companies
- GENOMICS: Genome Therapeutics Prefers p53's Pathway
- Ribi Adds Another Adjuvant
- INDUSTRY NEWS: Dismal Showing for U.S. Biotech Stocks
- Testing Begins for Angiogenic Strategy
- HORMONES, GROWTH FACTORS Recombinant Glucagon Challenges Extracts
- Mycogen Wins Bt Patent Suit
- Two Pursue Hepatitis Therapy
- Novo, Genentech Settle Dispute
- Genzyme Pulls Out of Research Products
- Gene Implicated in Psychiatric Disorders
- Pfizer Completes NIF Phase I Trial
- Immunex, American Home Restructure Agreements
- CELL THERAPY: Tissue Engineering Approaches $435 M
- ANTIBODIES: MedImmune's Synagis Approved
- Patents to Advanced Tissue Sciences
- ENZYMES: Genzyme, Pharming Tackle Pompe's Disease
- Hemosol Cultures Red Blood Cells
- AGBIOTECH: Milestone in Monsanto Project